Stereotactic Ablative Radiotherapy Tops for Inoperable Early Non-Small-Cell Lung Cancer Stereotactic Ablative Radiotherapy Tops for Inoperable Early Non-Small-Cell Lung Cancer
Compared with standard radiotherapy, stereotactic ablative body radiotherapy (SABR) provides better local control and improved survival in patients with inoperable peripherally located stage 1 non-small-cell lung cancer (NSCLC), according to results of the CHISEL study.Reuters Health Information
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Radiology | Study